Could This 1 Detail Help Viking Therapeutics Top Eli Lilly and Novo Nordisk in the Weight Loss Drug Market?

Viking shares have soared recently on optimism about its program.Eli Lilly (LLY 1.57%) and Novo Nordisk (NVO 0.42%) have seen their revenue soar in recent times thanks to their weight loss drugs. The companies sell products that target key hormones involved in the regulation of blood sugar levels and appetite, and they've proven their efficacy in clinical trials and the real world.All of this has helped the companies' shares soar to record highs, and considering demand for these products, the gains may be f ...